Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $10,895 - $13,435
-1,095 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$9.81 - $15.4 $10,741 - $16,863
1,095 New
1,095 $12,000
Q4 2021

Feb 15, 2022

SELL
$12.09 - $14.68 $15,656 - $19,010
-1,295 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $1,656 - $1,891
-125 Reduced 8.8%
1,295 $18,000
Q2 2021

Nov 12, 2021

SELL
$12.97 - $16.15 $1,660 - $2,067
-128 Reduced 8.27%
1,420 $20,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $26,663 - $36,375
-1,962 Reduced 55.9%
1,548 $22,000
Q4 2020

Feb 18, 2021

BUY
$14.3 - $18.74 $50,193 - $65,777
3,510 New
3,510 $66,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.